Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy
Clinical trial NCT02451956 · COMPLETED
Trial details
- NCT number
- NCT02451956
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-07
- Primary completion
- 2019-05-24
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.